RSNA 2011 

Abstract Archives of the RSNA, 2011


SSA13-06

US-guided Treatment of Supraspinatus Tendinosis with Autologous Platelet Gel

Scientific Formal (Paper) Presentations

Presented on November 27, 2011
Presented as part of SSA13: Musculoskeletal (Interventions: Pain and Tumor Treatments)

Participants

Antonio Barile, Presenter: Nothing to Disclose
Armando Conchiglia, Abstract Co-Author: Nothing to Disclose
Ada Riva, Abstract Co-Author: Nothing to Disclose
Lucrezia Marica Gentile, Abstract Co-Author: Nothing to Disclose
Francesco Arrigoni, Abstract Co-Author: Nothing to Disclose
Luigi Zugaro, Abstract Co-Author: Nothing to Disclose
Carlo Masciocchi, Abstract Co-Author: Nothing to Disclose

PURPOSE

Evaluate the efficacy and safety of the treatment of tendinosis of the Supraspinatus tendon with platelet gelToday, tendinosis and not-acute injuries of the tendons are not treated surgically, but using drugs and physical therapy to reduce pain and, consequently, improve function. The platelet gel is employed in the therapy of tendonitis due to its anti-inflammatory effect that reduces pain and its regenerative action on the tissue which allows improvement of function.

METHOD AND MATERIALS

We evaluated thirty-five patients with tendinosis of supraspinatus tendon. The patients were evaluated from both the clinical and functional points of view by VAS (for pain) and Constant Scale (for functionality). The instrumental evaluation was based on US and MRI. In particular, the morphological recovery of the lesions after treatment was assessed by independent review of MR images performed by three radiologists. Our protocol included three US-guided infiltrations at a distance of 21 days between each other, preceded by clinical, functional and US assessments.

RESULTS

The MRI control was performed both before treatment and 30 days after the last infiltration. The mean VAS at the end of treatment improved overall by 75% (from 6.86 to 1.7), the Constant scale by 55.4% (from 55.2 to 85.8). In twenty-nine patients (29/34 85%), post procedural MRI control showed disappearance of inflammatory signs. Tendon thickness, evaluated on MRI, results decreased in 16/34 (47%) cases by 5-15%. We observed a complete normalization of MRI signal in 11/34 (35%) patients and a partial normalization in 12/34 (41%) cases.  

CONCLUSION

Though the good clinical improvement observed by imaging, the recovery was only discrete. This study shows that the use of platelet gel, giving considerable results in terms of symptoms and function in patients with tendinosis, nevertheless produces only discrete morphological improvement. These results suggest the need of further studies on a larger population and longer term follow-up to assess the possibility to promote tissue regeneration with the employment of this technique.

CLINICAL RELEVANCE/APPLICATION

This study shows that the use of platelet gel, giving considerable results in terms of symptoms and function in patients with tendinosis

Cite This Abstract

Barile, A, Conchiglia, A, Riva, A, Gentile, L, Arrigoni, F, Zugaro, L, Masciocchi, C, US-guided Treatment of Supraspinatus Tendinosis with Autologous Platelet Gel.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11012750.html